NASDAQ: PPBT
Purple Biotech Ltd Stock Ownership - Who owns Purple Biotech?

Insider buying vs selling

Have Purple Biotech Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PPBT insiders and whales buy or sell their stock.

PPBT Shareholders

What type of owners hold Purple Biotech Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gil Efron0.73%15,750,000$25.67MInsider
Michael Schickler0.43%9,254,472$15.08MInsider
Shai S. Lankry0.16%3,550,000$5.79MInsider
Simcha Rock0.15%3,207,690$5.23MInsider
Ido Agmon0.14%3,093,860$5.04MInsider
Suzana Zilberberg0.14%3,062,500$4.99MInsider
Robert E. Gagnon0.14%3,062,500$4.99MInsider
Smartharvest Portfolios LLC0.00%51$83.13Institution
Hrt Financial LP0.00%18$29.34Institution
Jane Street Group LLC0.00%14$22.82Institution

1 of 2

PPBT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PPBT0.00%1.89%
AZTR0.04%99.96%
XBIO0.00%100.00%
IMNN0.00%100.00%Net BuyingNet Buying
SILO0.01%10.29%Net Buying

Purple Biotech Stock Ownership FAQ

Who owns Purple Biotech?

Purple Biotech (NASDAQ: PPBT) is owned by 0.00% institutional shareholders, 1.89% Purple Biotech insiders, and 98.11% retail investors. Gil Efron is the largest individual Purple Biotech shareholder, owning 15.75M shares representing 0.73% of the company. Gil Efron's Purple Biotech shares are currently valued at $26.46M.

If you're new to stock investing, here's how to buy Purple Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.